Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Short- and long-term real-world survival for metastatic bile duct cancer, 2000 to 2018.
Authors
Sarah Jeanne Wood
Emory University Hospital, Decatur, GA;
Sarah Jeanne Wood , Van Nghiem , Grant Richard Williams , Ravi Kumar Paluri , Darryl Alan Outlaw , Olumide B. Gbolahan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 523)
DOI
10.1200/JCO.2023.41.4_suppl.523
Abstract #
523
Poster Bd #
B13
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Epidemiological biliary tract cancer characterization: A patient cohort from the Spanish RETUD registry.
First Author: Teresa Macarulla
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Treatment patterns and clinical outcomes among patients with biliary tract cancers in a large commercially insured US population.
First Author: Adriana Valderrama
Poster
2014 Genitourinary Cancers Symposium
Glandular metastasis as a surrogate for long survivors in metastatic renal carcinoma.
First Author: Brice Chanez
Poster
2024 ASCO Annual Meeting
Comparative analysis of pembrolizumab and cetuximab-based therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma: Real-world data.
First Author: Zahra Hamedi